Samuel Nwite
AUTHOR: Samuel Nwite
Nvidia-Backed Iambic Files for IPO as Biotech Defies a Choppy US Listing Market
Iambic Therapeutics, a drug developer backed by Nvidia and Qatar's sovereign wealth fund, has filed for a U.S. initial public offering, adding another biotechnology...
Tesla Enters Vietnam EV Market, But Faces Homegrown Giant VinFast
Tesla is laying the groundwork to enter Vietnam, targeting one of Southeast Asia’s fastest-growing electric vehicle markets but also one where a powerful domestic...
Meta’s Muse AI Agent Is Promising to Save Users $1,000. Businesses Are Already Pushing...
Meta's new AI agent Muse is being marketed as something more consequential than a chatbot: a digital assistant that can act on behalf of...
Alibaba Bets on 10 Trillion-Parameter AI Model and Homegrown Chips in China’s Race to...
Alibaba is escalating its push to compete in artificial intelligence, announcing plans for an AI model potentially four times larger than its current flagship...
Nasdaq Hits Record as AI Stocks Rally, Oil Falls and Treasury Yields Ease
US stocks rebounded sharply on Monday, with the Nasdaq Composite closing at a record high as investors returned to AI and semiconductor shares, while...